Rachel King - 12 Nov 2024 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Alan Musso as attorney-in-fact for Rachel King
Issuer symbol
FULC
Transactions as of
12 Nov 2024
Net transactions value
$0
Form type
3
Filing time
14 Nov 2024, 16:10:03 UTC
Previous filing
14 Jun 2024
Next filing
02 Jan 2025

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney